Safety and Efficacy of Bepotastine Besilate Nasal Product in Seasonal Allergic Rhinitis Patients.

Trial Profile

Safety and Efficacy of Bepotastine Besilate Nasal Product in Seasonal Allergic Rhinitis Patients.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Jan 2014

At a glance

  • Drugs Bepotastine (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 15 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Oct 2010 New source identified and integrated (ClinicalTrials.gov).
    • 15 Oct 2010 Actual end date 1 Aug added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top